Protagonist Therapeutics Current Deferred Revenue (Quarterly) Analysis

Protagonist Therapeutics, Inc. (PTGX)

86.81 -1.12 (-1.27%) USD | NASDAQ | Dec 30, 10:33

View Current Deferred Revenue (Quarterly) for PTGX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Johnson & Johnson	--
ADMA Biologics, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Bristol Myers Squibb Co.	--
MannKind Corp.	Upgrade